Cargando…

Clinicopathological Characteristics of Papillary Thyroid Cancer in Children with Emphasis on Pubertal Status and Association with BRAFV600E Mutation

OBJECTIVE: Papillary thyroid cancer (PTC) may behave differently in prepubertal children as compared to pubertal children and adults. BRAF gene activating mutations may associate with PTC by creating aberrant activation. We aimed to evaluate the clinicopathological characteristics of PTC patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poyrazoğlu, Şükran, Bundak, Rüveyde, Baş, Firdevs, Yeğen, Gülçin, Şanlı, Yasemin, Darendeliler, Feyza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596798/ https://www.ncbi.nlm.nih.gov/pubmed/28077340 http://dx.doi.org/10.4274/jcrpe.3873

Ejemplares similares

Klinefelter Syndrome in Childhood: Variability in Clinical and Molecular Findings
por: Akcan, Neşe, et al.
Publicado: (2018)

Puberty and Pubertal Growth in Healthy Turkish Girls: No evidence for secular trend
por: Bundak, Rüveyde, et al.
Publicado: (2008)

Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome
por: YETİM ŞAHİN, Aylin, et al.
Publicado: (2019)

Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone
por: Saygılı, Seha, et al.
Publicado: (2023)

Long-term Follow-up of a Toddler with Papillary Thyroid Carcinoma: A Case Report with a Literature Review of Patients Under 5 Years of Age
por: Öztürk, Ayşe Pınar, et al.
Publicado: (2022)

Long-Term Endocrinologic Follow-Up of Children with Brain Tumors and Comparison of Growth Hormone Therapy Outcomes: A Single-Center Experience
por: Yavaş Abalı, Zehra, et al.
Publicado: (2023)

Is Premature Thelarche in the First Two Years of Life Transient?
por: Uçar, Ahmet, et al.
Publicado: (2012)

Reduced atherogenic indices in prepubertal girls with precocious adrenarche born appropriate for gestational age in relation to the conundrum of DHEAS
por: Uçar, Ahmet, et al.
Publicado: (2012)

Z-Score Reference Values for Height in Turkish Children Aged 6 to 18 Years
por: Günöz, Hülya, et al.
Publicado: (2014)

Epidemiologic Features of Type 1 Diabetic Patients between 0 and 18 Years of Age in İstanbul City
por: Demir, Fikri, et al.
Publicado: (2015)

Reference Values for Weight, Height, Head Circumference, and Body Mass Index in Turkish Children
por: Neyzi, Olcay, et al.
Publicado: (2015)

Evaluation of Permanent Growth Hormone Deficiency (GHD) in Young Adults with Childhood Onset GHD: A multicenter study
por: Berberoğlu, Merih, et al.
Publicado: (2008)

Mutations in AR or SRD5A2 Genes: Clinical Findings, Endocrine Pitfalls, and Genetic Features of Children with 46,XY DSD
por: Akcan, Neşe, et al.
Publicado: (2022)

A Patient with 22q11.2 Deletion Syndrome: Case Report
por: Eryılmaz, Sema Kabataş, et al.
Publicado: (2009)

Permanent Neonatal Diabetes Mellitus: Same Mutation, Different Glycemic Control with Sulfonylurea Therapy on Long-Term Follow-up
por: Küçükemre Ay, Banu, et al.
Publicado: (2012)

A Novel Homozygous Mutation of the Acid-Labile Subunit (IGFALS) Gene in a Male Adolescent
por: Poyrazoğlu, Şükran, et al.
Publicado: (2019)

A Rare Cause of Congenital Adrenal Hyperplasia: Clinical and Genetic Findings and Follow-up Characteristics of Six Patients with 17-Hydroxylase Deficiency Including Two Novel Mutations
por: Kardelen, Aslı Derya, et al.
Publicado: (2018)

Growth Hormone/Insulin-Like Growth Factor-1 Axis as Related to Body Mass Index in Patients with Idiopathic Short Stature
por: Cengiz, Pınar, et al.
Publicado: (2013)

Comparison of National Growth Standards for Turkish Infants and Children with World Health Organization Growth Standards
por: Bundak, Rüveyde, et al.
Publicado: (2022)

The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
por: Li, Yangsen, et al.
Publicado: (2022)

Severe Short Stature: an unusual finding in lipoid proteinosis
por: Poyrazoğlu, Şükran, et al.
Publicado: (2008)

The Distribution of Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism in the Turkish Population
por: Baş, Firdevs, et al.
Publicado: (2011)

Body proportions in patients with Turner syndrome on growth hormone treatment
por: KARDELEN, Aslı Derya, et al.
Publicado: (2022)

The Role of American Thyroid Association Pediatric Thyroid Cancer Risk Stratification and BRAF(V600E) Mutation in Predicting the Response to Treatment in Papillary Thyroid Cancer Patients ≤18 Years Old
por: Giles Şenyürek, Yasemin, et al.
Publicado: (2022)

Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy
por: Rostami, Elham, et al.
Publicado: (2017)

BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
por: Silver, Jennifer A., et al.
Publicado: (2021)

OR09-4 Novel Murine Models of BrafV600E driven Papillary Thyroid Cancer
por: Casado Medrano, Victoria, et al.
Publicado: (2022)

Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review
por: Andrews, Lily J, et al.
Publicado: (2021)

Diagnostic Efficacy of BRAFV600E Immunocytochemistry in Thyroid Aspirates in Bethesda Category IV and Papillary Thyroid Carcinoma
por: Anand, Nidhi, et al.
Publicado: (2021)

A Novel Pathogenic IGSF1 Variant in a Patient with GH and TSH Deficiency Diagnosed by High IGF-I Values at Transition to Adult Care
por: Kardelen, Aslı Derya, et al.
Publicado: (2023)

Iodine nutritional status is not a direct factor in the prevalence of the BRAFV600E mutation in papillary thyroid cancer
por: Lin, Yan-Yu, et al.
Publicado: (2023)

SUN-077 Do Low Sex Hormone Binding Globulin Levels in Newborns Predict Weight Gain in Infancy and Early Childhood?
por: Aydin, Banu Kucukemre, et al.
Publicado: (2020)

Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in Indonesian National Referral Hospital
por: Harahap, Agnes Stephanie, et al.
Publicado: (2023)

Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression
por: Harahap, Agnes Stephanie, et al.
Publicado: (2023)

Clinical and Laboratory Characteristics of Children Referred for Early Puberty: Preponderance in 7-8 Years of Age
por: Kılıç, Ayşe, et al.
Publicado: (2012)

Relation Between F-18 FDG Uptake of PET/CT and BRAFV600E Mutation in Papillary Thyroid Cancer
por: Yoon, Seokho, et al.
Publicado: (2015)

Unfavorable efficacy to (131)I ablation in BRAFV600E mutant papillary thyroid carcinoma with positive TgAb
por: Zhang, Na, et al.
Publicado: (2017)

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
por: Cheng, Lingxiao, et al.
Publicado: (2017)

Identification of R-Spondin Gene Signature Predictive of Metastatic Progression in BRAFV(600E)-Positive Papillary Thyroid Cancer
por: da Silva, Sabrina Daniela, et al.
Publicado: (2022)

CYP21A2 Gene Mutations in Congenital Adrenal Hyperplasia: Genotype−phenotype correlation in Turkish children
por: Baş, Firdevs, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gieo1alu0g31acuvci12m62g2s